NRC Health (NRC) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
9 Jun, 2026Business overview and mission
Provides healthcare experience insights and improvement solutions, combining rich data, workflow software, and predictive insights for leadership.
Mission is to help health systems understand every person they serve and turn insights into actions for improved outcomes.
Trusted by 75% of top-100 U.S. health systems, with 25M+ patient engagements annually.
Holds a leading presence in healthcare experience management, ranked #1 by KLAS Research.
Financial performance and growth
Achieved record $152M Total Recurring Contract Value (TRCV), up 13% year-over-year.
Q1 2026 revenue grew 4% year-over-year to $35M, marking the first y/y growth quarter since 2023.
Adjusted EBITDA margin at 27% for Q1 2026, with $0.25 adjusted free cash flow per share, up 8% y/y.
99% of revenue is recurring, with multi-year contracts and high correlation between TRCV and future revenue.
2025 full-year revenue was $137M, with $40M adjusted EBITDA and 21% adjusted FCF margin.
Market opportunity and business model
$5B total addressable market, with $0.7B cross-sell opportunity among existing customers.
Highly differentiated, healthcare-focused business model with significant barriers to entry.
End-to-end solution suite covers patient experience, enablement, strategic insights, and governance.
AI-powered intelligence transforms behavioral signals into predictive, high-impact actions.
Latest events from NRC Health
- Strong recurring revenue, AI-driven growth, and a major new client highlight future momentum.NRC
16th Annual East Coast IDEAS Conference10 Jun 2026 - High-quality rounding and improved communication drive stronger patient loyalty outcomes.NRC
Status update27 May 2026 - Key votes include director elections, auditor ratification, and major governance amendments.NRC
Proxy filing8 May 2026 - Proxy seeks approval for board declassification, governance reforms, and executive compensation changes.NRC
Proxy filing8 May 2026 - Record TRCV, 4% revenue growth, and the largest contract ever signed; $9.4M Q2 expense expected.NRC
Q1 20266 May 2026 - Proxy seeks approval for board declassification, governance reforms, and executive pay alignment.NRC
Proxy filing29 Apr 2026 - Q4 2025 revenue rose 2%, TRCV up 8% YoY, and a $0.16 dividend was declared.NRC
Q4 20253 Feb 2026 - Huey AI enhances healthcare experience management with tailored, ethical, and privacy-focused solutions.NRC
Status Update3 Feb 2026 - Timely, representative feedback and focus on key drivers accelerate patient experience improvement.NRC
Status update2 Feb 2026